đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to obtain safety and immunogenicity data for t...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00444860
Treatments Being Tested
The purpose of this study is to determine whether Zoster Vaccine Live and P...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00535730
A study in two parts (Part A and Part B) to evaluate the responsiveness of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00886613
Treatments Being Tested
The purpose of this study is to demonstrate that an investigational refrige...
Status
Completed
Location
Multiple Locations
Start Date
2002-09-26
Trial ID
NCT00092430
This study assesses non-inferiority by comparing seroconversion rate of NBP...
Status
Completed
Location
De La Salle Health Sciences Institute
Start Date
2016-07-14
Trial ID
NCT03114943
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391
This study will assess the safety and immunogenicity of ProQuad when admini...
Status
Completed
Location
Multiple Locations
Start Date
2000-06
Trial ID
NCT00984295
This study will test the safety, tolerability, and immunogenicity of VARIVA...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00822237
This study will compare ProQuad⢠and concomitant administration of M-M-R⢠I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
To observe the safety and tolerability of the administration of VARIVAX in ...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-22
Trial ID
NCT00496327
Treatments Being Tested